Crisaderm Ointment

Crisaborole topical
2% W/V
Incepta Pharmaceuticals Ltd.
Pack size 1's Pack
Unite Price 500.00 BDT

Indications

Crisaderm Ointment is used for: Indicated for mild-to-moderate atopic dermatitis

Adult Dose

Topical Atopic Dermatitis Indicated for mild-to-moderate atopic dermatitis Apply a thin layer topically to affected area(s) BID

Child Dose

Atopic Dermatitis Indicated for mild to moderate atopic dermatitis in infants and children aged ?3 months <3 months: Safety and efficacy not established >3 months: Apply a thin layer topically to affected area(s) BID

Renal Dose

Administration

Topical Administration Apply thin layer of ointment to affected areas BID Wash hands after applying ointment, unless hands are being treated For topical use only; not for ophthalmic, oral, or intravaginal use

Contra Indications

History of hypersensitivity to crisaborole or any component of the formulation

Precautions

Hypersensitivity reactions reported, including contact urticaria; signs and symptoms may include severe pruritus, swelling, and erythema at the application site or at a distant site; discontinue immediately and initiate appropriate therapy if hypersensitivity suspected

Pregnancy-Lactation

Pregnancy There are no available data in pregnant women to inform the drug-associated risk for major birth defects and miscarriage Crisaborole is systemically absorbed Lactation Unknown if distributed in human breast milk Crisaborole is systemically absorbed Consider the developmental and health benefits of breastfeeding along with the mother’s clinical need for the drug, and any potential adverse effects on the breastfed infant from the drug or from the underlying maternal condition

Interactions

Side Effects

Side effects of Crisaborole topical : 1-10% Application site pain, burning, or stinging (4%) <1% Contact urticaria

Mode of Action

Phosphodiesterase (PDE)-4 inhibitor; results in increased intracellular cyclic adenosine monophosphate (cAMP) levels The specific mechanism by which crisaborole exerts its therapeutic action for atopic dermatitis is not well defined, although cAMP is thought to decrease the proinflammatory response (eg, cytokine release) associated with atopic dermatitis

Note

Crisaderm 2% W/V Ointment generic name is Crisaborole topical. Crisaderm 2% W/V Ointment is manufactured by Incepta Pharmaceuticals Ltd.Crisaderm is availble in all over Bangladesh. Mes BD drug index information on Crisaderm Ointment is not intended for diagnosis, medical advice or treatment; neither intended to be a substitute for the exercise of professional judgment.

Some other brands of Crisaborole topical :